Breast Cancer Screening & Self-Exam: A Complete Guide

Breast cancer has quietly become the most common cancer among women in Bangladesh, overtaking cervical cancer, according to a report published in February 2026. The International Agency for Research on Cancer (IARC) estimated roughly 12,989 new breast cancer cases among Bangladeshi women in a single recent year — and unlike in Western countries, a growing body of local research shows the disease is striking women here at a noticeably younger age. Yet population-level screening remains rare, awareness of warning signs is low, and many women only seek care after a lump has grown large enough to be alarming. This guide explains what actually raises risk, how to recognize early warning signs, how screening and diagnosis work, and what is realistically available in Bangladesh today.

Why This Is an Urgent Issue in Bangladesh Right Now

A 2026 study based in Dhaka found that breast cancer incidence had doubled to 8.3% among women in the 35–40 age group, prompting researchers to argue that screening in Bangladesh should begin at age 35 rather than the 40–50 age range commonly used in Western screening guidelines. Bangladesh does not yet have a national, population-based cancer registry, so exact nationwide incidence figures are uncertain — but the government's own screening dashboard recorded more than 3 million clinical breast examinations between 2019 and 2026, with roughly 1% returning a positive finding. In October 2026, the health minister announced plans to expand breast cancer screening to the grassroots level, acknowledging that access has so far been concentrated in a handful of urban centers.

What Breast Cancer Is and How It Develops

Breast cancer begins when cells in the breast — usually in the milk ducts or the milk-producing lobules — start growing uncontrollably. Not all breast cancers behave the same way: some are driven by hormones (hormone-receptor-positive), some by a protein called HER2, and some are "triple-negative," meaning they lack all three common drivers. This subtype matters a great deal for treatment choice, which is one reason a biopsy (not just imaging) is required before any treatment decision is made.

Risk Factors You Cannot Change

• Age: risk rises with age, though Bangladeshi data suggests a younger risk curve than in high-income countries.
• Family history: having one first-degree relative (mother, sister, daughter) with breast cancer roughly doubles personal risk; two affected first-degree relatives roughly triples it.
• Inherited gene mutations (BRCA1/BRCA2): these account for a small share of all breast cancers (around 5%), but carriers face a lifetime risk as high as 60–80%.
• Reproductive history: never having a full-term pregnancy, having a first pregnancy after age 30, or not breastfeeding are each associated with modestly higher risk.

Risk Factors You Can Influence

• Body weight: excess weight, especially after menopause, raises risk; weight gained in adulthood counts more than weight present since childhood.
• Alcohol: risk rises with the amount consumed, and no level has been shown to be completely risk-free.
• Physical inactivity: regular physical activity is associated with lower risk.
• Long-term hormone therapy: risk increases the longer combined hormone therapy is used after menopause.

Symptoms: It Is Not Always a Lump

About 1 in 6 women diagnosed with breast cancer never had a lump at all — which is exactly why relying on "I didn't feel anything" can be dangerous. Warning signs include:

• A new lump or area of thickening that feels different from the surrounding tissue
• Swelling of all or part of the breast, even without a distinct lump
• Skin dimpling, puckering, or a texture resembling orange peel
• Persistent redness or a rash on the breast skin or around the nipple
• Nipple inversion (turning inward) that is new, not lifelong
• Nipple discharge, particularly if it happens spontaneously (without squeezing), occurs in only one breast, or is blood-tinged
• Persistent breast or underarm pain that does not follow the menstrual cycle and does not resolve

A Rare but Dangerous Pattern: Inflammatory Breast Cancer

Inflammatory breast cancer is an aggressive subtype that almost never presents as a lump. Instead, the breast becomes red, warm, swollen, and may look and feel like an infection (mastitis). Because it is often mistaken for infection, treatment is sometimes delayed. Any breast redness or swelling that does not improve after a short course of antibiotics, or that worsens rapidly, needs prompt evaluation — not repeated rounds of antibiotics.

Breast Self-Exam: How to Actually Do It

Breast self-examination (BSE) is not a substitute for clinical screening, and research has not shown that it reduces breast cancer deaths when mammography is already available. But in a country where routine mammography access is still limited, BSE remains one of the few tools every woman can use for free, and it helps you learn what is normal for your own body so you notice genuine changes faster.

When: Pick the same time every month — ideally a few days after your period ends, when breast tissue is least swollen. After menopause, choose any fixed day each month.

1. Look: Stand in front of a mirror with your arms at your sides, then raised overhead. Compare both breasts for differences in size, shape, skin texture, or nipple position.
2. Feel standing (often done in the shower): Using the pads of your three middle fingers, make small circular motions covering the entire breast and armpit area, moving from the outer edge toward the nipple. Repeat with the arm raised.
3. Feel lying down: Place a pillow under the shoulder of the side being examined and raise that arm overhead. Use the opposite hand to press with light, then medium, then firm pressure across the whole breast and underarm. Gently check the nipple for discharge.
4. Follow up on anything new: A self-exam finding is never a diagnosis on its own — have it checked by a doctor, and continue with mammograms as advised regardless of self-exam results.

Clinical Screening: Clinical Breast Exam, Mammogram, and Ultrasound

In resource-limited settings, the World Health Organization has long emphasized clinical breast examination (CBE) — a physical exam performed by a trained health worker or doctor — as a more feasible first-line screening tool than population-wide mammography, which requires significant infrastructure. This is reflected in Bangladesh's own national program: the government's screening dashboard is built primarily around CBE data rather than mammography data.

Where mammography is available, major international bodies differ somewhat on the ideal starting age: the US Preventive Services Task Force recommends biennial mammograms from age 40 to 74 for women at average risk, while the older WHO position paper advised caution about routinely offering mammography to women under 50 in settings without a fully resourced screening program. Given the Bangladeshi data showing incidence rising sharply by the mid-30s, researchers in Dhaka have specifically argued for starting structured screening discussions at age 35 for Bangladeshi women, rather than waiting until 40 or later. Talk to a doctor about what is appropriate for your individual risk profile, especially if you have a family history.

When imaging is done, radiologists grade findings using the BI-RADS scale (0 to 6): a score of 1 or 2 is generally reassuring, while 4 or 5 usually leads to a recommendation for biopsy. Ultrasound is commonly used alongside mammography, particularly to tell a solid lump apart from a simple fluid-filled cyst. A biopsy — most often a core needle biopsy — is the only way to confirm or rule out cancer; imaging alone cannot provide a diagnosis.

Staging

Once a biopsy confirms cancer, doctors determine the stage, which ranges from Stage 0 (non-invasive, contained within the ducts) to Stage IV (spread to distant organs such as bone, liver, or lungs). Staging, along with the cancer's hormone-receptor and HER2 status, guides the treatment plan.

Differentiating From Common Benign Conditions

Most breast lumps, especially in younger women, turn out to be benign. A fibroadenoma is a smooth, firm, mobile lump common in women in their 20s and 30s. Breast cysts are fluid-filled and often tender, fluctuating with the menstrual cycle. Mastitis (breast infection, common during breastfeeding) causes redness, warmth, and pain, usually with fever, and typically improves with antibiotics within days — unlike inflammatory breast cancer. None of these conditions can be reliably distinguished from cancer by feel alone, which is why any new or persistent breast change deserves a clinical evaluation rather than a guess.

Special Considerations

• Younger women: because Bangladeshi data shows a disproportionate number of cases in the 35–40 range, young age should not be used to dismiss a genuine lump or symptom.
• Pregnant and breastfeeding women: breast changes are common and usually benign, but a lump that persists for more than two to three weeks, or any bloody nipple discharge, should still be checked — ultrasound is generally the safest first imaging step during pregnancy.
• Women with a strong family history or known BRCA mutation: these women may benefit from earlier and more frequent screening, including MRI in some cases, and should have an individualized plan made with a specialist.
• Older women: screening benefit and risk should be weighed individually past the mid-70s, taking overall health and life expectancy into account, rather than applying a blanket cutoff.

When to See a Doctor Promptly

Seek medical evaluation without delay for: a new lump (even if a recent mammogram was normal), spontaneous or blood-tinged nipple discharge, a persistent change in breast or nipple shape or skin, or redness/swelling that does not improve with a short course of antibiotics. Do not wait for pain to appear — many early breast cancers cause no pain at all.

Treatment: A Brief Overview

Treatment is individualized based on stage, subtype, and overall health, and is decided by an oncology team — this is general background only, not a treatment recommendation. Options generally include surgery (breast-conserving surgery or mastectomy), radiation therapy, and systemic treatment such as chemotherapy. For hormone-receptor-positive cancers, hormone-blocking medicines such as tamoxifen or aromatase inhibitors like letrozole may be used for an extended period as prescribed by a specialist. For HER2-positive cancers, targeted therapies are used alongside other treatments. Never start or stop any of these medicines without a prescribing oncologist's guidance.

Getting Screened in Bangladesh

The National Institute of Cancer Research & Hospital (NICRH) in Dhaka and other government hospitals offer breast cancer services, including clinical breast examination, at government-fixed, low-cost rates, and have periodically run free screening campaigns. That said, reports have noted that mammography equipment at some government facilities has been non-functional for extended periods, so availability can vary by location and time — it is worth calling ahead to confirm a mammogram unit is working before traveling. Private hospitals and diagnostic centers in major cities also offer mammography and ultrasound, generally at higher cost. If cost or access to mammography is a barrier, a clinical breast exam by a trained doctor is a reasonable and far better option than no screening at all.

Prevention: What You Can Actually Do

• Limit alcohol intake as much as possible
• Maintain a healthy body weight, particularly after menopause
• Stay physically active regularly
• Breastfeed where possible, for as long as feasible
• Discuss the risks and benefits of long-term hormone therapy with your doctor if you are considering or using it
• Know your family history and share it with your doctor

No lifestyle change eliminates risk entirely, which is why awareness of warning signs and appropriate screening remain essential alongside prevention.

Sources: International Agency for Research on Cancer (IARC/GLOBOCAN), World Health Organization (WHO) guidance on breast cancer screening in resource-limited settings, the US Preventive Services Task Force (USPSTF), Bangladesh's National Cervical & Breast Cancer Screening Programme dashboard, and published Bangladeshi clinical research on age-specific breast cancer incidence.